Gene Therapy Market Size, Assessment, Value, Share, Growth, Trends, Competition, Industry Analysis, Actionable Insights Report; By Indication, By Vector Type, By Type of Therapy, By Delivery Method, By Route of Administration, By Region and By Country; Outlook and Forecasts, 2024 – 2030
Table of Contents
1. Report Introduction and Overview
1.1. Objectives of the Study
1.2. Definition of Gene Therapy
1.3. Scope and Description of Gene Therapy Market
1.4. Timelines and Years Considered for the Study
1.4.1. Historical Data Analysis and Trends, 2019 - 2023
1.4.2. Current and Forecast Data Analysis and Outlook, 2024 - 2030
1.5. Market Segmentations
1.5.1. Indication of Global Gene Therapy Market
1.5.2. Vector Type of Global Gene Therapy Market
1.5.3. Type of Therapy of Global Gene Therapy Market
1.5.4. Delivery Method of Global Gene Therapy Market
1.5.5. Route of Administration of Global Gene Therapy Market
1.5.6. Region of Global Gene Therapy Market
2. Executive Summary Dashboard
2.1. Global Gene Therapy Market Overview
2.2. Global Gene Therapy Market Size Share (%) and Growth Rate % (Year-on-Year) from 2019 to 2030
2.3. Global Gene Therapy Market Size Assessment, Revenue (US$ Bn), Market CAGR (%), Market Forecasts (2024 - 2030)
2.4. Global Gene Therapy Market Size Assessment, Market CAGR (%), Market Forecast (2024 - 2030), By Segments
2.5. Global Gene Therapy Market Size Assessment, Market CAGR (%), Market Forecast (2024 - 2030), By Regions
2.6. Absolute Market Opportunity Assessment
2.6.1. Total Addressable/Available Market (TAM)
2.6.2. Serviceable Addressable Market (SAM)
2.6.3. Serviceable Obtainable Market (SOM)
2.7. Market Attractiveness
2.8. Ecology/Ecosystem Mapping
2.9. Product/Solution/Service Life Cycle
2.10. Competition Landscape Snapshot
3. Research Methodology
3.1. Data Mining
3.1.1. External Paid Sources / Databases
3.1.2. Vertex Internal Proprietary Database
3.1.3. Secondary Data and Sources
3.1.4. Primary Research
3.1.5. Third-Party Perspectives
3.2. Subject Matter Expert (SME) Insights
3.3. Data Triangulation & Data Analysis Models
3.3.1. Bottom-Up Approach
3.3.2. Top-Down Approach
3.3.3. Estimation & Forecasts, by Variables
3.3.4. Data Models Testing and Validation
3.4. Key Insights from Industry Experts & Partners
3.5. Market Formulation and Data Visualization
3.6. Quality Check
3.7. Final Review
3.8. Assumptions
3.9. Limitations
3.10. Report FAQs
4. Gene Therapy Industry – Dynamics and Trends Analysis
4.1. Gene Therapy Market Evolution
4.2. Russia-Ukraine War Impacts Analysis
4.3. Inflation Impacts Analysis
4.3.1. Supply Side Impacts
4.3.2. Demand Side Impacts
4.3.3. Outlook in 2024 & Beyond
4.4. Top Trends to Watch Out
4.4.1. Trend1
4.4.2. Trend2
4.4.3. Trend3
4.4.4. Trend4
4.4.5. Trend5
4.5. Market Adoption/Penetration Rate Analysis
4.6. Gene Therapy Market Dynamics, By Region
4.6.1. Drivers
4.6.2. Limitations
4.6.3. Opportunities
4.6.4. Impact Analysis of Drivers and Restraints
4.7. Ecosystem/Value Chain Analysis
4.7.1. Biomaterials/Equipment/Technology Suppliers
4.7.2. Manufacturers & Contract Organizations
4.7.3. Distributors
4.7.4. Buyers/End-users
4.7.5. Forward Integration & Backward Integration of Key Stakeholders
4.8. Global Gene Therapy Market - Pricing Trends Analysis & Average Selling Prices (ASPs)
4.9. End-User/Customer Preferences & Consumer Surveys’ Insights
4.10. Technology Roadmap & Key Innovations/Developments
4.11. Key Mandates & Regulatory Scenario Analysis
4.12. Patents Landscape
4.13. Cost Structure Share Analysis
4.14. Sustainability and Environmental Impacts Analysis
4.15. Key Mergers & Acquisitions, Expansions, Partnerships/JVs, Funding / VCs, etc.
5. Gene Therapy Industry - Strategic Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of Substitutes
5.1.4. Threat of New Entrants
5.1.5. Competitive Rivalry / Degree of Competition
5.2. PEST Analysis
5.2.1. Political Factors
5.2.2. Economic Factors
5.2.3. Social Factors
5.2.4. Technological Factors
5.3. SWOT Analysis
5.4. ANSOFF Matrix Analysis
5.4.1. Market Penetration Strategy
5.4.2. Product/Solution/Service Development Strategy
5.4.3. Market Development Strategy
5.4.4. Diversification Strategy
5.5. Macroeconomic Factors
5.6. Market Investment Feasibility Analysis
5.7. Opportunity Map Analysis
5.8. Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Regions
6. Premium Insights
6.1. Attractive Market Opportunities (Key Investment Pockets)
6.2. Market Investment Scenario
6.3. Demand & Supply Scenario
6.4. Top 3 Strategies Implemented by Major Players
6.5. Global Gene Therapy Market – Gross Profit Margins
6.6. Top 3 Regions/Geographies
6.7. Key Insights from Primary Respondents
6.8. Top 3 Projections & Recommendations by Vertex
7. Global Gene Therapy Market Sizes & Historical Trends Analysis (2019 - 2023)
8. Global Gene Therapy Market Sizes & Forecast Trend Analysis, by Indication
8.1. Global Gene Therapy Market Revenue (US$ Bn) Estimates and Forecasts, by Indication, 2019 to 2030
8.1.1. Cancer (Oncology)
8.1.1.1. Acute Lymphoblastic Leukemia (ALL)
8.1.1.2. Head & Neck Squamous Cell Carcinoma
8.1.1.3. Large B-cell Lymphoma
8.1.1.4. Melanoma (Lesions)
8.1.2. Inherited Retinal Disease
8.1.3. ADA-SCID
8.1.4. Beta-Thalassemia Major / SCD
8.1.5. Peripheral Arterial Disease
8.1.6. Spinal Muscular Atrophy (SMA)
8.1.7. Other Indications
9. Global Gene Therapy Market Sizes & Forecast Trend Analysis, by Vector Type
9.1. Global Gene Therapy Market Revenue (US$ Bn) Estimates and Forecasts, by Vector Type, 2019 to 2030
9.1.1. Adeno-Associated Virus (AAV)
9.1.2. Adenovirus
9.1.3. Herpes Simplex Virus
9.1.4. Lentivirus
9.1.5. Retrovirus
9.1.6. Non-Viral Vectors
9.1.7. Others
10. Global Gene Therapy Market Sizes & Forecast Trend Analysis, by Type of Therapy
10.1. Global Gene Therapy Market Revenue (US$ Bn) Estimates and Forecasts, by Type of Therapy, 2019 to 2030
10.1.1. Gene Augmentation
10.1.2. Gene Silencing
10.1.3. Cell / Gene Replacement
10.1.4. Others
11. Global Gene Therapy Market Sizes & Forecast Trend Analysis, by Delivery Method
11.1. Global Gene Therapy Market Revenue (US$ Bn) Estimates and Forecasts, by Delivery Method, 2019 to 2030
11.1.1. In Vivo
11.1.2. Ex Vivo
12. Global Gene Therapy Market Sizes & Forecast Trend Analysis, by Route of Administration
12.1. Global Gene Therapy Market Revenue (US$ Bn) Estimates and Forecasts, by Route of Administration, 2019 to 2030
12.1.1. Intravenous
12.1.2. Others
13. Global Gene Therapy Market Sizes & Forecast Trend Analysis, by Region
13.1. Global Gene Therapy Market Revenue (US$ Bn) Estimates and Forecasts, by Region, 2019 to 2030
13.1.1. North America
13.1.2. Europe
13.1.3. Asia Pacific
13.1.4. Middle East & Africa
13.1.5. South America
14. North America Gene Therapy Market Sizes & Forecast Trend Analysis
14.1. North America Gene Therapy Market Assessments & Key Findings
14.1.1. North America Gene Therapy Market Introduction
14.1.2. North America Gene Therapy Market Sizes, Forecast, and Shares (US$ Bn) (2019 to 2030)
14.1.2.1. By Indication
14.1.2.2. By Vector Type
14.1.2.3. By Type of Therapy
14.1.2.4. By Delivery Method
14.1.2.5. By Route of Administration
14.1.2.6. By Country
14.1.2.6.1. U.S.
14.1.2.6.2. Canada
14.1.2.6.3. Mexico
15. Europe Gene Therapy Market Sizes & Forecast Trend Analysis
15.1. Europe Gene Therapy Market Assessments & Key Findings
15.1.1. Europe Gene Therapy Market Introduction
15.1.2. Europe Gene Therapy Market Sizes, Forecast, and Shares (US$ Bn) (2019 – 2030)
15.1.2.1. By Indication
15.1.2.2. By Vector Type
15.1.2.3. By Type of Therapy
15.1.2.4. By Delivery Method
15.1.2.5. By Route of Administration
15.1.2.6. By Country
15.1.2.6.1. Germany
15.1.2.6.2. U.K.
15.1.2.6.3. France
15.1.2.6.4. Italy
15.1.2.6.5. Spain
15.1.2.6.6. Rest of Europe
16. Asia Pacific Gene Therapy Market Sizes & Forecast Trend Analysis
16.1. Asia Pacific Market Assessments & Key Findings
16.1.1. APAC Gene Therapy Market Introduction
16.1.2. APAC Gene Therapy Market Sizes, Forecast, and Shares (US$ Bn) (2019 – 2030)
16.1.2.1. By Indication
16.1.2.2. By Vector Type
16.1.2.3. By Type of Therapy
16.1.2.4. By Delivery Method
16.1.2.5. By Route of Administration
16.1.2.6. By Country
16.1.2.6.1. China
16.1.2.6.2. Japan
16.1.2.6.3. India
16.1.2.6.4. Australia
16.1.2.6.5. South Korea
16.1.2.6.6. ASEAN
16.1.2.6.7. Rest of Asia Pacific
17. Middle East & Africa Gene Therapy Market Sizes & Forecast Trend Analysis
17.1. Middle East & Africa Market Assessments & Key Findings
17.1.1. MEA Gene Therapy Market Introduction
17.1.2. MEA Gene Therapy Market Sizes, Forecast, and Shares (US$ Bn) (2019 – 2030)
17.1.2.1. By Indication
17.1.2.2. By Vector Type
17.1.2.3. By Type of Therapy
17.1.2.4. By Delivery Method
17.1.2.5. By Route of Administration
17.1.2.6. By Country
17.1.2.6.1. U.A.E.
17.1.2.6.2. Saudi Arabia
17.1.2.6.3. Egypt
17.1.2.6.4. South Africa
17.1.2.6.5. Rest of Middle East & Africa
18. South America Gene Therapy Market Sizes & Forecast Trend Analysis
18.1. South America Market Assessments & Key Findings
18.1.1. South America Gene Therapy Market Introduction
18.1.2. South America Gene Therapy Market Sizes, Forecast, and Shares (US$ Bn) (2019 – 2030)
18.1.2.1. By Indication
18.1.2.2. By Vector Type
18.1.2.3. By Type of Therapy
18.1.2.4. By Delivery Method
18.1.2.5. By Route of Administration
18.1.2.6. By Country
18.1.2.6.1. Brazil
18.1.2.6.2. Argentina
18.1.2.6.3. Colombia
18.1.2.6.4. Rest of South America
19. Competition Landscape
19.1. Gene Therapy Market Competition Index, By Leading Players
19.2. Gene Therapy Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants
19.3. Gene Therapy Market Competition White Space Analysis, By Application / End-user
19.4. Gene Therapy Market Competition Heat Map Analysis, By Products / Services / Solutions
19.5. Gene Therapy Market Competition Regional Intensity Map Analysis, By Geographies Served
19.6. Gene Therapy Market Concentration & Company Market Shares (%) Analysis, 2022
19.7. Gene Therapy Market Competition Quadrant Analysis, By Leading Players / Innovators / Emerging Players / New Entrants
20. Company Profiles
20.1. American Gene Technologies
20.1.1. Company Overview & Key Facts
20.1.2. Revenues, Financial Performance & KPIs
20.1.3. Products / Solutions / Services Portfolio & Applications / End-users
20.1.4. Business Strategies
20.1.5. Recent Key Developments
*Similar detailed Profiles would be provided for all the players mentioned below
20.2. Amgen
20.3. AnGes
20.4. Astellas Pharma
20.5. AstraZeneca
20.6. BENITEC BIOPHARMA
20.7. Biogen
20.8. BioMarin Pharmaceutical
20.9. Bluebird Bio
20.10. Bristol-Myers Squibb Company
20.11. Cellectis
20.12. CRISPR Therapeutics
20.13. CSL Behring
20.14. Epeius Biotechnologies
20.15. Gene Biotherapeutics
20.16. Gensight Biologics
20.17. Gilead Lifesciences
20.18. Novartis
20.19. Orchard Therapeutics
20.20. Oxford BioMedica
20.21. Pfizer
20.22. REGENXBIO
20.23. Roche
20.24. Sangamo Therapeutics
20.25. SANOFI
20.26. Shanghai Sunway Biotech
20.27. Shenzhen Sibiono GeneTech
20.28. Vertex Pharmaceuticals
20.29. Others** (subject to your specific additional requirements)
21. Research Findings & Conclusion
FAQ'S
What is Global Gene Therapy Market Growth?
The global gene therapy market is expected to grow at a compound annual growth rate (CAGR) of around 21% from 2024 to 2030.
What are the Factors Driving the Gene Therapy Market?
The growth of the gene therapy market is driven by several key factors, including a surge in approvals from regulatory bodies, expanded genomics clinical research initiatives, a growing emphasis on advanced targeted gene therapies, and the widening scope of gene delivery technologies. Additionally, competition among key players to commercialize gene therapies, the escalating prevalence of genetic disorders, increased research and development activities, and a growing geriatric population contribute significantly. Elevated healthcare expenditure, heightened health awareness among the general populace, and medical research organizations' intensified focus on potential cures for rare, genetic, and autoimmune diseases also propel this growth. Moreover, the market also benefits from a strong and expanding gene therapy pipeline.
How Big is Global Gene Therapy Market?
The global gene therapy market size in terms of revenue was estimated to be around USD 9 Billion in 2023.
Which Segment Accounted for Largest Share of Global Gene Therapy Market?
In 2023, spinal muscular atrophy (SMA) emerged as the dominant segment, securing a substantial share exceeding 40%. Despite its rarity, SMA ranks among the most prevalent and fatal inherited disorders in infants. The introduction of Zolgensma (AVXS-101) has proven its effectiveness in treating SMA, notably altering the disease's phenotype. In May 2019, the FDA granted approval for Novartis' Zolgensma, targeting the root cause of SMA. Currently, Zolgensma stands as the sole approved gene treatment in this field, marking a significant step in adopting therapies for combating severe hereditary conditions such as SMA.
Who are the Key Players in Gene Therapy Market?
Some of the key players operating in the gene therapy market include American Gene Technologies, Amgen, AnGes, Astellas Pharma, AstraZeneca, BENITEC BIOPHARMA, Biogen, BioMarin Pharmaceutical, Bluebird Bio, Bristol-Myers Squibb Company, Cellectis, CRISPR Therapeutics, CSL Behring, Epeius Biotechnologies, Gene Biotherapeutics, Gensight Biologics, Gilead Lifesciences, Novartis, Orchard Therapeutics, Oxford BioMedica, Pfizer, REGENXBIO, Roche, Sangamo Therapeutics, SANOFI, Shanghai Sunway Biotech, Shenzhen Sibiono GeneTech, Vertex Pharmaceuticals, and Others.
How will I Receive this Report and Data?
Based on your selected License Type, you will receive the report in various downloadable formats, including PDF, PPT, Word, and Data Pack (Spreadsheet) files.
Key Insights Delivered
Historical and Current Market Assessment
Market Outlook, Forecasts, and Growth Rates
Segments and Regional Forecasts for Market Intelligence
Competition Strategy and Company Market Shares Analysis
Customer Analysis and Purchase Pattern Analysis
Key Growth and Driving Factors
Key Opportunities in the Market
Products and Services Innovation Listing
Key Technological Trends & Timeline
Regulatory and Policy Analysis
Why Choose Us?
Specialized Industry Focus for In-Depth Insights
Robust Research Methodology Validated by Industry Experts and Survey Panelists
Quality and Accuracy Assurance
Availability in Different Formats
Free Post-Sales Uninterrupted Service
Permission to Print
Free Report Walkthrough / Presentation by Dedicated Account Manager
Free 20% or 40 Hours of Customization
Avail Special Discount on Your Next Purchase
Subscription Packages Available
Customization Options
Specific Region/Country Level Market Assessment
Additional Segmentations of Consumers/ Products/ Services/ Applications
Cross-Segmentation of Demand and Supply Side Segments
Customized Market Forecasting and Trend Analysis
Customized Competitive Landscape and Company Profiles Tailored to Your Marketplace and Interests
Additional Survey Panels for Custom Insights
Other Specific Customization Requirements
clients
quick contact
Related report
Subscribe to Our Newsletter
